Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Qingsong Health Co., Ltd. (6931:TWSE), powered by AI.
Qingsong Health Co., Ltd. is currently trading at $70.10. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Qingsong Health Co., Ltd. on Alpha Lenz.
View Qingsong Health Co., Ltd.'s valuation metrics on Alpha Lenz.
“Qingsong Health Co., Ltd.'s ROE is 6.4%. Explore profitability and growth together.”
Ask for details →Qingsong Health Co., Ltd., a notable entity in the healthcare sector, focuses on providing a range of medical services and solutions primarily within the pharmaceutical and healthcare product distribution space. The company is involved in the research, development, and commercialization of health-related products, enhancing the accessibility of medical treatments and preventive care options across various regions. Known for its strategic partnerships and collaborations with both domestic and international firms, Qingsong Health Co., Ltd. plays a significant role in the supply chain of healthcare products, ensuring efficient distribution to healthcare facilities and pharmacies. The company's impact extends across multiple industries, influencing sectors such as biotechnology, medical equipment, and pharmaceuticals. By continuously adapting to innovations in medical technology and regulatory changes, Qingsong Health Co., Ltd. sustains its relevance and competitiveness in the global market, contributing to advancements in healthcare solutions and improving the quality of health services available to the population.
“Qingsong Health Co., Ltd.'s ROE is 6.4%. Explore profitability and growth together.”
Ask for details →Qingsong Health Co., Ltd. (ticker: 6931) is a company listed on TWSE in the Healthcare sector (Medical Care Facilities).
The current price is 70.1 with a P/E ratio of -x and P/B of -x.
ROE is 6.40% and operating margin is 4.49%. Annual revenue is $983M.